SBIO

ALPS Medical Breakthroughs ETF
*Unless otherwise stated, data provided by FactSet.

SBIO Fund Description

SBIO tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials.

SBIO Factset Analytics Insight

SBIO invests in a concentrated portfolio of biotech companies with drugs in Phase II and Phase III of U.S. Food and Drug Administration (FDA) clinical trials, and limits itself to US-listed firms with market caps between USD 200 million and USD 5 billion. SBIO also screens for sustainability, meaning constituent firms have enough cash on hand to last two years. Given the low historical success rates in clinical trials, the fund is a high-risk, high-reward bet on a small subset of biotech companies. The Underlying Index undergoes semi-annual reconstitution and quarterly rebalance subject to certain caps. The largest stock is capped at 4.5%, and the excess weight is redistributed proportionately over the remainder of the Underlying Index. Prior to July 9, 2019 the fund’s index was Poliwogg Medical Breakthroughs Index, which has the same strategies.

PERFORMANCE [as of 06/23/22] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
SBIO 5.69% -16.01% -33.19% -42.20% -7.75% 0.68% --
SBIO (NAV) 5.89% -16.05% -33.19% -42.24% -7.69% 8.83% --
S-Network Medical Breakthroughs Index 6.27% -15.68% -32.83% -41.87% -7.33% 1.00% --
MSCI USA IMI / Biotechnology -IND -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

SBIO Summary Data

SS&C
ALPS
12/31/14
Open-Ended Fund
0.50%
$92.44M
$817.38K
0.30%
IBB, XBI, FBT, PBE, BBP

SBIO Portfolio Data

$1.98B
-7.79
2.74
0.03%
N/A
130

SBIO Index Data

S-Network Medical Breakthroughs Index
Market Cap
Fundamental
MSCI USA IMI / Biotechnology -IND

SBIO Portfolio Management

0.50%
-0.23%
-0.14%
-0.50%

SBIO Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

SBIO Fund Structure

Open-Ended Fund
No
Yes
-- / --
N/A
N/A
Low
Daily

SBIO Factset Analytics Block Liquidity

As of 06/24/22
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of SBIO. SBIO is rated a 5 out of 5.

SBIO Tradability

30,626
$817.38K
26,545
$687.24K
0.30%
$0.08
-0.11%
0.23% / -1.28%
None
84.00%
25,000
1.06
0.02%
0.06%
333
$28.24
5

SBIO Sector/Industry Breakdown


SBIO
Segment Benchmark
99.30%
--
0.68%
--
0.02%
--
0.00%
--

SBIO Countries


SBIO
Segment Benchmark
92.03%
--
3.51%
--
1.96%
--
1.45%
--
0.86%
--
0.19%
--

SBIO Regions


SBIO
Segment Benchmark
92.89%
--
6.92%
--
0.19%
--

SBIO Economic Development


SBIO
Segment Benchmark
100.00%
--

SBIO Performance Statistics

--
--
--
--
--
MSCI USA IMI / Biotechnology -IND

SBIO Benchmark Comparison Holdings

130
--
--
--

SBIO Benchmark Comparison Summary


SBIO
Segment Benchmark
130
--
$1.98B
--
-7.79
--
2.74
--
0.07%
--
Low
--

SBIO Benchmark Comparison Market Cap Size


SBIO
Segment Benchmark
0.00%
--
25.53%
--
55.55%
--
18.92%
--